The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study
In this cohort study comparing two brand-name fluticasone-salmeterol inhalers prescribed for COPD in routine clinical practice, effectiveness and safety outcomes were similar for patients receiving metered-dose and dry powder versions.
Authors
- Shirley Wang (ORCID: https://orcid.org/0000-0001-7761-7090)
- William B. Feldman (ORCID: https://orcid.org/0000-0003-3467-5869)
- Brandon J. Demkowicz (ORCID: https://orcid.org/0000-0002-0107-8032)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Kevin Rader
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1371/journal.pmed.1004596
- Citations
- 2
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- National Heart, Lung, and Blood Institute